Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse-Reference-Cited by-同舟云学术

Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse

Published:2013-08 Issue:8 Volume:21 Page:1507-1516
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Boisgerault Nicolas,Kottke Timothy,Pulido Jose,Thompson Jill,Diaz Rosa Maria,Rommelfanger-Konkol Diana,Embry Addie,Saenz Dyana,Poeschla Eric,Pandha Hardev,Harrington Kevin,Melcher Alan,Selby Peter,Vile Richard

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference40 articles.

1. Models, mechanisms and clinical evidence for cancer dormancy;Aguirre-Ghiso;Nat Rev Cancer,2007

2. Does tumour dormancy offer a therapeutic target?;Goss;Nat Rev Cancer,2010

3. Clinical opportunities and challenges in targeting tumour dormancy;Hensel;Nat Rev Clin Oncol,2013

4. Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches;McGowan;Future Oncol,2009

5. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing;Gerlinger;N Engl J Med,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy;Seminars in Cancer Biology;2024-05

2. Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses;Molecular Therapy - Oncolytics;2023-06

3. MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?;Cancers;2022-09-01

4. Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer;Cancer Drug Resistance;2022

5. Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy;Nature Communications;2021-03-26